These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 2069375)

  • 1. Efficacy of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine in various models of herpes simplex virus infection in mice.
    De Clercq E; Holý A
    Antimicrob Agents Chemother; 1991 Apr; 35(4):701-6. PubMed ID: 2069375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful treatment of progressive mucocutaneous infection due to acyclovir- and foscarnet-resistant herpes simplex virus with (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC).
    Snoeck R; Andrei G; Gérard M; Silverman A; Hedderman A; Balzarini J; Sadzot-Delvaux C; Tricot G; Clumeck N; De Clercq E
    Clin Infect Dis; 1994 Apr; 18(4):570-8. PubMed ID: 8038312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of phosphonylmethoxyalkyl derivatives of adenine in experimental herpes simplex virus and vaccinia virus infections in vivo.
    De Clercq E; Holý A; Rosenberg I
    Antimicrob Agents Chemother; 1989 Feb; 33(2):185-91. PubMed ID: 2719463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of the treatment protocol upon the in vivo efficacy of cidofovir (HPMPC) and of acyclovir (ACV) formulations in topical treatment of cutaneous HSV-1 infection in hairless mice.
    Afouna MI; Mehta SC; Ghanem AH; Higuchi WI; Kern ER; DeClercq E; El-Shattawy HH
    J Pharm Sci; 1999 May; 88(5):530-4. PubMed ID: 10229644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Azone upon the in vivo antiviral efficacy of cidofovir or acyclovir topical formulations in treatment/prevention of cutaneous HSV-1 infections and its correlation with skin target site free drug concentration in hairless mice.
    Afouna MI; Fincher TK; Zaghloul AA; Reddy IK
    Int J Pharm; 2003 Mar; 253(1-2):159-68. PubMed ID: 12593946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphonylmethoxyalkyl purine and pyrimidine derivatives for treatment of opportunistic cytomegalovirus and herpes simplex virus infections in murine AIDS.
    De Castro LM; Kern ER; De Clercq E; Ghaffar A; Mayer EP; Vogt PE; Gangemi JD
    Antiviral Res; 1991 Jul; 16(1):101-14. PubMed ID: 1663726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged and potent therapeutic and prophylactic effects of (S)-1-[(3-hydroxy-2-phosphonylmethoxy)propyl]cytosine against herpes simplex virus type 2 infections in mice.
    Yang H; Datema R
    Antimicrob Agents Chemother; 1991 Aug; 35(8):1596-600. PubMed ID: 1929331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment with intravenous (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]-cytosine of acyclovir-resistant mucocutaneous infection with herpes simplex virus in a patient with AIDS.
    Lalezari JP; Drew WL; Glutzer E; Miner D; Safrin S; Owen WF; Davidson JM; Fisher PE; Jaffe HS
    J Infect Dis; 1994 Sep; 170(3):570-2. PubMed ID: 8077713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic potential of Cidofovir (HPMPC, Vistide) for the treatment of DNA virus (i.e. herpes-, papova-, pox- and adenovirus) infections.
    De Clercq E
    Verh K Acad Geneeskd Belg; 1996; 58(1):19-47; discussion 47-9. PubMed ID: 8701600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)-cytosine and 9-(1,3-dihydroxy-2-propoxymethyl)-guanine in the treatment of intracerebral murine cytomegalovirus infections in immunocompetent and immunodeficient mice.
    Neyts J; Sobis H; Snoeck R; Vandeputte M; De Clercq E
    Eur J Clin Microbiol Infect Dis; 1993 Apr; 12(4):269-79. PubMed ID: 8390357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-acting therapy of viral retinitis with (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine.
    Flores-Aguilar M; Huang JS; Wiley CA; De Clercq E; Vuong C; Bergeron-Lynn G; Chandler B; Munguia D; Freeman WR
    J Infect Dis; 1994 Mar; 169(3):642-7. PubMed ID: 8158041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of phosphonylmethoxyalkyl-purine and -pyrimidine derivatives on TK+ and TK- HSV-1 keratitis in rabbits.
    Maudgal PC; De Clercq E
    Antiviral Res; 1991 Jul; 16(1):93-100. PubMed ID: 1663731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of HPMPC therapy for primary and recurrent genital herpes in mice and guinea pigs.
    Bravo FJ; Stanberry LR; Kier AB; Vogt PE; Kern ER
    Antiviral Res; 1993 May; 21(1):59-72. PubMed ID: 8391249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. (S)-1-(3-hydroxy-2-phosphonyl-methoxypropyl)cytosine in the therapy of thymidine kinase-positive and -deficient herpes simplex virus experimental keratitis.
    Maudgal PC; De Clercq E
    Invest Ophthalmol Vis Sci; 1991 May; 32(6):1816-20. PubMed ID: 1851733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC) against guinea pig cytomegalovirus infection in cultured cells and in guinea pigs.
    Li SB; Yang ZH; Feng JS; Fong CK; Lucia HL; Hsiung GD
    Antiviral Res; 1990 May; 13(5):237-52. PubMed ID: 2168690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antivirals for the treatment of herpesvirus infections.
    De Clercq E
    J Antimicrob Chemother; 1993 Jul; 32 Suppl A():121-32. PubMed ID: 8407694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine for the treatment of lethal vaccinia virus infections in severe combined immune deficiency (SCID) mice.
    Neyts J; De Clercq E
    J Med Virol; 1993 Nov; 41(3):242-6. PubMed ID: 8263505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine and 9-(1,3-dihydroxy-2-propoxymethyl)guanine for the treatment of murine cytomegalovirus infection in severe combined immunodeficiency mice.
    Neyts J; Balzarini J; Naesens L; De Clercq E
    J Med Virol; 1992 May; 37(1):67-71. PubMed ID: 1320099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of acyclovir-resistant herpes simplex virus.
    Chilukuri S; Rosen T
    Dermatol Clin; 2003 Apr; 21(2):311-20. PubMed ID: 12757254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cidofovir use in acyclovir-resistant herpes infection.
    Martinez CM; Luks-Golger DB
    Ann Pharmacother; 1997 Dec; 31(12):1519-21. PubMed ID: 9416391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.